<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Cellular response to <z:mp ids='MP_0005039'>hypoxia</z:mp> is mainly controlled by <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor 1 (HIF-1) </plain></SENT>
<SENT sid="1" pm="."><plain>The HIF-1 target gene erythropoietin (EPO) has been described as neuroprotective </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, we hypothesize EPO to be an essential mediator of protection in hypoxic preconditioning </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We randomized Sv129 mice into groups for different pretreatments, different <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> intervals, or different durations of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>For hypoxic preconditioning, the animals were exposed to a hypoxic gas mixture (8% O2 and 92% N2) for 30, 60, 180, 300, or 360 minutes </plain></SENT>
<SENT sid="5" pm="."><plain>At 0, 24, 48, 72, or 144 hours later, we performed middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and allowed reperfusion after 30, 45, 60, or 120 minutes, or occlusion was left to be permanent </plain></SENT>
<SENT sid="6" pm="."><plain>We studied EPO gene expression in brain tissue with a real-time reverse transcriptase-polymerase chain reaction and measured HIF-1 DNA-binding activity with an electrophoretic mobility shift assay </plain></SENT>
<SENT sid="7" pm="."><plain>To block endogenously produced EPO, we instilled soluble EPO receptor into the cerebral ventricle </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Hypoxic preconditioning for 180 or 300 minutes induced relative tolerance to transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, as evidenced by a reduction of <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes to 75% or 54% of the control, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Hypoxic pretreatment was effective only when applied 48 or 72 hours before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Sixty minutes after <z:mp ids='MP_0005039'>hypoxia</z:mp>, we found a marked activation of HIF-1 DNA-binding activity and a 7-fold induction of EPO transcription </plain></SENT>
<SENT sid="11" pm="."><plain>Infusion of soluble EPO receptor significantly reduced the protective effect of hypoxic pretreatment by 40% </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Endogenously produced EPO is an essential mediator of ischemic preconditioning </plain></SENT>
</text></document>